Long Covid Research Trials Near but Patients Want Swifter Action

Research trials for potential long Covid treatments are on the way from the Biden administration, but patients say the process lacks urgency and fails to take their needs fully into account as much of the country moves on from the Covid-19 pandemic.

In the coming months, the National Institutes of Health’s RECOVER research initiative into long Covid will launch its first clinical trials, in which multiple therapeutics will be tested against various symptoms associated with the affliction. Officials with the Health and Human Services Department, which oversees NIH, declined to provide a specific start date. But Adrian Hernandez, director of ...